Citation: Cs. Lau et al., LACK OF EVIDENCE OF ACTIVE LYTIC REPLICATION OF EPSTEIN-BARR AND CYTOMEGALOVIRUSES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Chinese medical journal, 111(7), 1998, pp. 660-665
Citation: Cc. Mok et al., TOXICITIES OF DAPSONE IN THE TREATMENT OF CUTANEOUS MANIFESTATIONS OFRHEUMATIC DISEASES, Journal of rheumatology, 25(6), 1998, pp. 1246-1247
Citation: Cc. Mok et al., ACUTE TRANSVERSE MYELOPATHY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - CLINICAL PRESENTATION, TREATMENT, AND OUTCOME, Journal of rheumatology, 25(3), 1998, pp. 467-473
Authors:
MOK CC
LEU CS
HO CTK
LEE KW
MOK MY
WONG RWS
Citation: Cc. Mok et al., SAFETY OF HORMONAL REPLACEMENT THERAPY IN POSTMENOPAUSAL PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Scandinavian journal of rheumatology, 27(5), 1998, pp. 342-346
Citation: Cc. Mok et al., RISK-FACTORS FOR AVASCULAR BONE NECROSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS, British journal of rheumatology (Print), 37(8), 1998, pp. 895-900
Citation: Cc. Mok et al., ARE MALES DIFFERENT FROM FEMALES IN CLINICAL MANIFESTATIONS, DISEASE COURSE AND DAMAGE IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 41(9), 1998, pp. 193-193
Citation: Ctk. Ho et al., COMPARISON OF THE EFFICACY OF INTERMITTENT INTRAVENOUS PULSE AND CONTINUOUS ORAL CYCLOPHOSPHAMIDE IN THE TREATMENT OF DIFFUSE PROLIFERATIVENEPHRITIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 41(9), 1998, pp. 450-450
Citation: My. Mok et al., SAFETY OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS) IN RHEUMATOID-ARTHRITIS (RA) PATIENTS WITH CHRONIC VIRAL-HEPATITIS, Arthritis and rheumatism, 41(9), 1998, pp. 740-740
Citation: Cc. Mok et al., CLINICAL CHARACTERISTICS, TREATMENT AND OUTCOME OF ADULT-ONSET STILLS-DISEASE IN SOUTHERN CHINESE, Arthritis and rheumatism, 41(9), 1998, pp. 1196-1196
Citation: Cs. Lau et al., EFFECTS OF CALCITRIOL VERSUS HORMONAL REPLACEMENT THERAPY IN STEROID-INDUCED OSTEOPOROSIS IN AMENORRHEIC PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 41(9), 1998, pp. 1620-1620
Citation: Cc. Mok et al., RISK-FACTORS FOR OVARIAN FAILURE IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS RECEIVING CYCLOPHOSPHAMIDE THERAPY, Arthritis and rheumatism, 41(5), 1998, pp. 831-837
Citation: Cc. Mok et al., RISK-FACTORS FOR AVASCULAR BONE NECROSIS (AVN) IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), Arthritis and rheumatism, 40(9), 1997, pp. 790-790
Citation: Kk. Tong et al., CD5- PLAQUE-FORMING CELLS (PFC) AGAINST POLY-L-LYSINE (PLL) TREATED SHEEP ERYTHROCYTES IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) - A LONGITUDINAL-STUDY( AND CD5), Arthritis and rheumatism, 40(9), 1997, pp. 800-800
Citation: Cs. Lau et al., REARRANGEMENT OF THE MANNOSE-BINDING LECTIN (MBL) GENE IS ASSOCIATED WITH THE DEVELOPMENT OF RHEUMATOID-ARTHRITIS (RA) IN SOUTHERN CHINESE, Arthritis and rheumatism, 40(9), 1997, pp. 1308-1308
Citation: Cc. Mok et al., ACUTE TRANSVERSE MYELOPATHY (ATM) IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), Arthritis and rheumatism, 40(9), 1997, pp. 1351-1351